Given the elevated risk of cardiovascular morbidity and mortality in individuals with mood disorders, including bipolar disorder, the cardiovascular benefits associated with GLP-1 agonists could offer another valuable protective mechanism, enhancing the overall health and well-being of patients
10.1016/j.cell.2009.07.017 81
15 4963 10.1038/nrm3722 [DOI] [PubMed] [Google Scholar] de Quay B., Malinverni R., Lauterburg B
Walker explains that he's not actually an employee of Calocurb but rather works for the New Zealand government as a scientist and researcher at what was then called Plant & Food Research , now part of the New Zealand Biosciences Economy Institute
The FDA is working to help address this issue as heavy metals in foods have been on consumers minds, as noted by consumer research conducted by the International Food Information Council (IFIC), due to high-profile recalls and adulteration
Both Wegovy and phentermine are proven medications, but their effectiveness can vary from person to person